HOME >> BIOLOGY >> NEWS
Vascular access vital to pump up tissue engineering

Palo Alto, Calif.-- March 30, 2004 -- Pathbreaking developments in tissue engineering and regenerative therapies are facilitating the design and growth of new organs in labs using biopolymer scaffolds and matrices. Analysis of potential markets for tissue engineering reveals that basic problems such as vascularity must be solved before such implants can gain acceptance as standard treatment methods.

"When a matrix or scaffold containing cells is implanted into a patient to treat large bone defects or complex organ damage, it is difficult to ensure that the implanted tissue construct has sufficient vascular access," says Technical Insights Analyst Katherine Austin." A construct can be kept alive in a bioreactor by constantly supplying it with nutrients and oxygen, but once it is implanted in the patient, it has to be well supplied by capillaries. You have to have sufficient perfusion reaching all of the cells or they'll die."

Significant research is being carried out seeking means to overcome this barrier.

Desktop organ printing based on several 3D computer aided design (CAD) processes that can 'print' tissues layer by layer is another method being tested. The components of blood vessels are laid down within the various layers and the tissue constructs grow their own capillaries when the appropriate growth factors and cells are added.

Apart from this physiological issue, another major factor that hinders acceptance of breakthrough technologies of tissue engineering as standards of practice is the reluctance of the medical community to accept them.

Physicians and surgeons are often traditionalists, and unless they approve of and use them, the products are unlikely to succeed. In fact, lack of confidence among surgeons and inadequate marketing strategies have led several products from prominent companies to fail.

Such failures make investors cautious. Investor confidence in the technology is also low since it is still so
'"/>

Contact: Julia Paulson
jpaulson@frost.com
210-247-3870
Technical Insights
30-Mar-2004


Page: 1 2

Related biology news :

1. Vascular disease and aging
2. Vascular Surgeons Test New Treatment For Abdominal Aneurysms
3. Study Links Viruses And Vascular Diseases
4. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
5. Keep genome data freely accessible
6. Oxford Journals takes bold step towards free access to research
7. ORNLs nanobiosensor technology gives new access to living cells molecular processes
8. American Society of Plant Biologists offers developing nations free access to science journals
9. Open access to Ohio research
10. Open access initiative from the Company of Biologists
11. Unemployment, access to guns among factors that turn domestic violence deadly

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special Counsel to ... of Identity Strategy Partners, LLP, today releases the following ... Protecting the Nation From Foreign Terrorist Entry Into the ... Trump,s ,Travel Ban, Executive Order gains more notoriety and ... ban, it is important that our national discourse regain ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... , March 27, 2017 Roka Bioscience, Inc. ... testing solutions for the detection of foodborne pathogens,  today announced ... Sidoti & Company Spring 2017 Convention on March 29 at ... York Marriott Marquis. About Roka Bioscience ... Roka ...
(Date:3/27/2017)... 2017 Infectex Ltd., a Russian portfolio company of Maxwell Biotech ... SQ109 added to the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis ... ( USA ) and the US National Institutes of Health. ... ... Fund Logo ...
(Date:3/27/2017)... , ... March 27, 2017 , ... PMG Research ... Collaborations (CTC) conference presented by The Conference Forum in Boston on April 3-4, ... collaborate to drive improved clinical trial outcomes and bring them closer to the patient. ...
(Date:3/27/2017)... NEW YORK , March 27, 2017 /PRNewswire/ ... company developing novel therapies for neurodegenerative diseases, including ... confirmation that its application to list the Company,s ... been approved by The NASDAQ Stock Market, a ... of the listing, Neurotrope will ring the Opening Bell ...
Breaking Biology Technology:
Cached News: